# Human African Trypanosomiasis: First in Man Clinical Trial of a New Medicinal Product, the SCYX-7158

> **NCT01533961** · PHASE1 · COMPLETED · sponsor: **Drugs for Neglected Diseases** · enrollment: 136 (actual)

## Conditions studied

- Trypanosomiasis
- Trypanosomiasis, African
- Protozoan Infections
- Parasitic Diseases

## Interventions

- **DRUG:** SCYX-7158
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01533961
- **Lead sponsor:** Drugs for Neglected Diseases
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2015-03
- **Final completion:** 2015-03
- **Target enrollment:** 136 (ACTUAL)
- **Last updated:** 2015-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01533961

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01533961, "Human African Trypanosomiasis: First in Man Clinical Trial of a New Medicinal Product, the SCYX-7158". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT01533961. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*